Last Updated on January 20, 2024 by The Health Master
The government yesterday said Zydus Cadila’s indigenously-developed needle-free C-19 vaccine ZyCoV-D will be introduced in the nationwide anti C-19 virus vaccination drive shortly and would have a differential pricing than the jabs being used currently.
As far as the price at which it will be procured is concerned, Rajesh Bhushan, Union Health Secretary, told a press conference that the government is in talks with the manufacturer.
“As far as the price of the vaccine at which it will be procured is concerned, we are in conversations with the manufacturer. Since it is a three-dose vaccine and comes with a needle-less delivery system, it would have a differential pricing than the existing vaccines that are being used in the C-19 vaccination programme,” he said.
“It will be introduced in the C-19 vaccination drive very shortly,” Bhushan added.
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI) and will be administered to people aged 12 years and above.
DCGI asks State FDAs to ensure uninterrupted supply of Medical Devices
Lilly cuts price of Insulin injection
BDR Pharma brings advanced cancer drug to India at affordable rates
Glenmark gets marketing approval for its Nasal Spray in 13 countries
FDA to check food licenses of all street vendors
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
